STAT Plus: Pharmalittle: Buttigieg releases sweeping drug pricing plan; opioid victims to play role in Purdue bankruptcy
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-predictable routine of deadlines, meetings, Skype calls, and whatever else you do to communicate has, of course, returned. To cope, yes, we are firing up the coffee kettle and quaffing cups of stimulation. After all, the neurons can use a little help. Our choice today is blueberry cobbler for those considering something adventurous. Meanwhile, here are some items of interest to help you on your own journey. Hope all goes well and, by all means, keep in touch. We enjoy hearings spilled secrets …
The appointment of a former pharmaceutical lobbyist to the National Institute on Drug Abuse’s top advisory body has outraged recovery advocates, who blame the industry for a nationwide overdose crisis that claimed more than 67,000 lives last year, BuzzFeed News writes. Jessica Hulsey Nickel, 43, heads the Brimley Group lobbying firm and the nonprofit Addiction Policy Forum. From 2014 to 2017, she was a registered lobbyist for Alkermes (ALKS), which makes the Vivitrol addiction treatment that sparked controversy over misleading marketing aimed at judges and jails.
Continue to STAT Plus to read the full story…
